End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,070 KRW | +1.47% | -0.24% | -9.41% |
03-20 | MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023. | CI |
Sales 2022 | 152B 111M 151M | Sales 2023 | 170B 123M 168M | Capitalization | 76.62B 55.7M 76.08M |
---|---|---|---|---|---|
Net income 2022 | 7.87B 5.72M 7.81M | Net income 2023 | -4.52B -3.29M -4.49M | EV / Sales 2022 | 1.12 x |
Net Debt 2022 | 73.17B 53.2M 72.66M | Net Debt 2023 | 78.82B 57.3M 78.27M | EV / Sales 2023 | 0.92 x |
P/E ratio 2022 |
12.3
x | P/E ratio 2023 |
-17.1
x | Employees | 283 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.71% |
1 day | +1.47% | ||
1 week | -0.24% | ||
Current month | -9.80% | ||
1 month | -5.91% | ||
3 months | -7.38% | ||
6 months | -8.41% | ||
Current year | -9.41% |
Managers | Title | Age | Since |
---|---|---|---|
Choon-Sik Park
CEO | Chief Executive Officer | 61 | - |
Seok-Min Woo
CHM | Chairman | 56 | 01-01-31 |
Jang-Ho Lee
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Seok-Min Woo
CHM | Chairman | 56 | 01-01-31 |
Yong-Jin Jeong
BRD | Director/Board Member | 59 | - |
Cheol-Han Bae
BRD | Director/Board Member | 72 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2,070 | +1.47% | 23,309 |
24-04-25 | 2,040 | -1.69% | 59,809 |
24-04-24 | 2,075 | +1.22% | 18,849 |
24-04-23 | 2,050 | +0.24% | 16,443 |
24-04-22 | 2,045 | -1.45% | 26,213 |
End-of-day quote Korea S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-9.41% | 50.43M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- A017180 Stock